SPANNR
Posts
Issue #170 - Fart Walk

Issue #170 - Fart Walk

This 10‐minute fix after big meals tames glucose, gas, and guilt, making you HAPPY 😊

September 18, 2025

September 18th, 2025 | Issue #170

Deep‑Dish Pizza Got You Down?

I’ve been there. Super burritos, all you can eat sushi, all the things to gorge yourself on, I've been there. (I ❤️ to eat if you can’t tell) This week, we break down why a short walk right after you eat is one of the lowest‑barrier longevity levers—plus the biggest metabolic headlines to know now.

Two Big Things This Week

🧪 Novo’s Wegovy pill is (nearly) the shot in tablet form — 16.6% weight loss over 64 weeks - HOLY $#!TWhy it matters: An oral GLP‑1 that approaches injection‑level efficacy could expand access and adherence. The Phase 3 OASIS‑4 results published Sept 18, 2025 showed 16.6% mean loss vs 2.7% placebo at 64 weeks; >33% lost ≥20%. FDA decision expected Q4 2025. Washington Post

💊 FDA okays the first generic GLP‑1 for weight loss (liraglutide/Saxenda) Why it matters: Approved Aug 28, 2025, Teva’s launch brings the first generic GLP‑1 indicated for obesity into U.S. pharmacies—potentially easing shortages and lowering costs for adolescents and adults who meet label criteria. Reuters

The Super Burrito Blues?

I’ve been there, you probably have too. This week, we break down why a short walk right after you eat is one of the lowest‑barrier longevity levers, and if you’re not doing this, WHY NOT?!? There is zero downside to this…

What problem are we solving?

Big meals spike glucose and bloat. You know this is true if you’ve even worn a CGM. The good news: Timing a short walk right after you eat can blunt those spikes and move gas along. In adults with type 2 diabetes, prescribing 10 minutes of walking after each meal lowered post‑meal glucose more than a single 30‑minute daily walk at any time. That’s not “more exercise”—it’s better‑timed movement.

What’s the evidence (human first)?

Two meta-analyses show that breaking up sitting with light walking results in meaningful reductions in postprandial glucose and insulin levels; walking outperforms standing. The American Diabetes Association’s 2025 Standards now emphasize breaking up sitting every 30 minutes with brief activity—exactly what a “fart walk” does after meals. For GI comfort, a randomized trial in people with functional bloating found short post‑meal activity improved belching, flatus, fullness, and discomfort—mechanistically consistent with speeding transit and reducing trapped gas.

How do I do it (practical, low‑barrier)?

Keep it light: think conversation‑pace, not a sweat session. (Unless you’re in Austin, then you’ll sweat no matter what!)
Start within 5–15 minutes after finishing, go 5–10 minutes, repeat after your largest two meals.
If you’re on insulin or hypoglycemia‑prone meds, talk to your clinician about dose timing as you add post‑meal walks.
Pair it with better bites: see our food heuristics “Monch Monch for Longevity.”

→ Put those carbs to rest, and yes, even with Monch Monch, you need to do ‘The Walk’

What’s next?

As oral GLP‑1s approach prime time, behavior + pharmacology will be a powerful combo. But regardless of meds, the fart walk remains a durable, free lever you can deploy today. We’re also tracking next‑gen biological age tools—if you experiment, do it thoughtfully (see our guide).

→ Testing is the way to go, don’t guesstimate - check out the best of the best here

TL;DR: A 5–10 minute walk started within 15 minutes after eating can flatten glucose spikes and ease bloat. It’s the lowest‑friction longevity habit we know—especially if you sit a lot.

MARKET INTEL (past 60 days; quick hits)

Regulatory — First FDA‑cleared Alzheimer’s blood test launches. Labcorp is now offering Fujirebio’s pTau‑217/Aβ42 ratio as the first FDA‑cleared blood‑based aid for Alzheimer’s diagnosis. So what: mainstream access may move specialty cognitive workups earlier and cheaper. U.S. Food and Drug Administration+1

Trials — BioAge doses first human with BGE‑102 (NLRP3 inhibitor). The first-in-human Phase 1 study is underway; initial safety and tolerability data are expected by year-end 2025. >>> So what: inflammasome targeting remains a hot aging‑biology bet with metabolic and neuro links. ir.bioagelabs.com

Public comps — Roche buying 89bio for up to $3.5B. Expands into MASH; metabolic pipelines continue to consolidate. >>> So what: validates liver‑metabolic adjacency as GLP‑1 halo lifts the whole category. Reuters

Access — New FDA voucher could fast‑track oral GLP‑1s. Analysts say Lilly’s orforglipron may be eligible, potentially shrinking review to 1–2 months. >>> So what: earlier pill competition could pressure prices. Reuters

Chart of the week: Forest plot from Buffey et al. (2022, Sports Medicine) showing effect sizes: light walking breaks significantly reduce post‑meal glucose vs sitting, and outperform standing. Link to paper (see Figures). ResearchGate

Stay classy, not gassy,Brent

__________________________________________________________

Have A Longevity Doc?Talk To A Longevity Provider Here for FREE!

This Week’s LONGEVITY PLAN in 3 Easy Steps

✅ Step 1: This week, track it: After two meals/day, start a 5–10 min walk within 15 min of finishing. Log start time + duration for 7 days (your phone's notes app works beautifully for this).

✅ Step 2: Make it accessible: Keep “walk shoes” by the door, set a 10‑minute timer, and pick a short “loop.” Pair with one food upgrade from Monch Monch for Longevity (linked above).

✅ Step 3: Forward‑looking: If you use glucose‑lowering meds (insulin, sulfonylureas), ask your clinician how post‑meal activity may affect doses/timing; consider a 2‑week CGM trial to see your post‑meal curves.

Bottom Line: The billionaires aren't just buying themselves extra decades—they're building the entire industry infrastructure that will eventually benefit everyone. We just need to be smart about riding their wake.

CITY GUIDE SPOTLIGHT

Chicago — Speaking of Deep‑dish pizza, walk it off on the Lakefront Trail, then bookmark Chicago’s best longevity‑minded clinicians—from metabolic to hormones—curated by Spannr. Explore the Windy City’s complete guide → Chicago’s best of the best Clinics and Docs, all right here

Sources for this newsletter this week: Research compiled from 30+ longevity publications, biotech funding reports, clinical trial databases, and longevity company materials.Medical disclaimer: Content is for educational purposes only and is not medical advice. Please always consult a qualified healthcare professional before making any changes to your health regimen.Affiliate disclosure: Spannr may receive compensation when you click partner links and make a purchase. Some products may be provided at no cost for evaluation; opinions are our own.HIPAA/PHI notice: Do not send personal medical information to this inbox. Spannr does not collect or store PHI via email.

ABOUT SPANNRWe are building Your Gateway to Longevity. Through unique insights, we provide unbiased information about health and life extending strategies. With our marketplace, you can browse through the services and products that are right for you. If you have any questions about Spannr or want to get to know us better, contact us – we'd love to hear from you. We appreciate your interest in what we are creating.